Real World Study with Benralizumab in Severe Asthma in Switzerland

Trial Identifier: D3250R00048
Sponsor: AstraZeneca
NCTID:: NCT03907137
Start Date: January 2019
Primary Completion Date: January 2023
Study Completion Date: January 2023

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Switzerland Aathal, Switzerland, 8607
Switzerland Basel, Switzerland, 4031
Switzerland Bern, Switzerland, 3010
Switzerland Chur, Switzerland, 7000
Switzerland Geneva, Switzerland, 1211
Switzerland Liestal, Switzerland, 4410
Switzerland Luzern, Switzerland, 6000
Switzerland Sion, Switzerland, 1950
Switzerland Wetzikon, Switzerland, 8620
Switzerland Zurich, Switzerland, 8006
Switzerland Zurich, Switzerland, 8032
Switzerland Zurich, Switzerland, 8044